MRNA

Check out the companies making headlines in premarket trading. Regeneron Pharmaceuticals (REGN) — Regeneron shares fell more than 1% in the premarket after the company said its Covid-19 antibody cocktail and similar drugs could be less effective against the omicron Covid variant. The drugmaker said mutations in the variant suggest “there may be reduced neutralization
0 Comments
Dr. Scott Gottlieb, a Pfizer board member, told CNBC that people should get their boosters as soon as possible because breakthrough infections are occurring more than the public realizes. The Centers for Disease Control and Prevention cleared Pfizer and Moderna boosters for all adults on Friday. The agency previously cleared Johnson & Johnson boosters. Anyone
0 Comments
Check out the companies making headlines in midday trading. United Airlines, Boeing — Shares of travel-related stocks dipped after Austria announced earlier in the day that it would reenter a full national lockdown due to a spike in Covid cases. United Airlines fell about 3.2% while American dipped 1%. Boeing fell 4.9%. Devon Energy, Hess Corporation
0 Comments
The CDC still has to authorize distribution of the booster doses before people can start receiving the shots, which could start this weekend. The CDC’s independent panel of vaccine experts is scheduled to meet on Friday to review the new data. CDC Director Rochelle Walensky on Wednesday said the public health agency would “act swiftly”
0 Comments
Arkansas, Colorado, Louisiana, Kansas, Kentucky, Maine, New Mexico, Vermont and West Virginia are promoting the widespread rollout of boosters for any fully vaccinated adult. New York and Rhode Island are asking adults in high-transmission areas to get boosted, while New Jersey and Minnesota are planning to expand eligibility in the days ahead. California’s also asking
0 Comments
Moderna defended the use of its Covid-19 vaccine Thursday, saying the protection it offers against severe disease, hospitalization and death outweighs the risk of myocarditis, a rare heart condition seen in a small number of young men who received the shot. The company announced last week that the Food and Drug Administration needed more time
0 Comments
National Institutes of Health Director Dr. Francis Collins is advising fully vaccinated Americans to get their Covid booster shots to prevent breakthrough cases over the holidays, citing data from Israel that showed the waning effectiveness of Pfizer and BioNTech’s Covid-19 vaccine against the delta variant. The team from Technion-Israel Institute of Technology, Haifa, analyzed nearly
0 Comments
Check out the companies making headlines in midday trading. Moderna — Moderna shares tumbled 19% after a weaker-than-expected quarterly report. The drug maker cut its Covid-19 vaccine sales forecast for the year and missed third-quarter earnings and revenue expectations. Moderna earned $7.70 per share for its latest quarter versus the $9.05 Refinitiv consensus estimate. Penn National
0 Comments
The FDA needs more time to complete its assessment of Moderna’s Covid-19 vaccine for 12-to-17-year-olds before granting emergency use authorization, the drugmaker said in a statement Sunday. The review may not be completed until January 2022. Moderna said the Food and Drug Administration will need more time to complete its assessment of the biotech company’s Covid-19
0 Comments
At least 1.5 million Americans received a booster shot of either Moderna’s or J&J’s Covid-19 vaccine in the first five days after U.S. regulators authorized the extra doses, a White House official said. “Our booster program is off to a very strong start,” Jeff Zients, the White House coronavirus response coordinator, told reporters. At least
0 Comments
A new study found that nearly two-thirds of long-term Covid patients reported “brain fog,” which included memory loss. “Our work and the work of others has shown that this affects people’s abilities to make plans, synthesize information, and do their daily activities of work,” said David Putrino, the Director of Rehabilitation Innovation at Mount Sinai
0 Comments
More than 47 million Pfizer vaccine recipients who received both shots at least six months ago became eligible for a booster Friday. More than 39.1 million Moderna vaccine recipients who received both shots at least six months ago became eligible for a booster Friday. The CDC adopted a slightly different criteria for J&J’s one-shot Covid
0 Comments
Harvard University associate professor Dr. Joseph Allen argued in favor of pulling back on masking children in schools. “We have to be careful that, if we don’t set firm deadlines, it’s easy to see how we can sleepwalk into indefinite masking,” said Allen. “We should be mandating vaccines for all adults in schools,” said Allen.
0 Comments
Formally known as AY.4.2, the delta plus subvariant includes two new mutations to the spike protein, A222V and Y145H, which allow the virus to enter the body. The AY.4.2 subvariant has been detected in at least five cases in the U.S.: Washington, D.C., California, North Carolina, Washington state and Massachusetts. Francois Balloux, the director of
0 Comments
An influential CDC advisory committee on Thursday unanimously recommended boosters of Moderna and Johnson & Johnson’s Covid-19 vaccines. While the endorsement isn’t binding, CDC Director Dr. Rochelle Walensky is expected to give her final approval as early as this evening. More than 39 million Moderna recipients and nearly 13 million J&J recipients may be eligible
0 Comments